Fidelity Group of Funds > FIDELITY COVINGTON TRUST
Fidelity MSCI Health Care Index ETF
$3.03B
Avg Monthly Net Assets
$3.05B
Total Assets
$216K
Total Liabilities
$3.05B
Net Assets
Fidelity MSCI Health Care Index ETF is an Exchange-Traded Fund in FIDELITY COVINGTON TRUST
from Fidelity Group of Funds,
based in Massachusetts,
United States of America.
The fund has one share class
and monthly net assets of $3.03B.
On September 25th, 2024 it reported 368 holdings, the largest
being Eli Lilly & Co (10.3%), UnitedHealth Group Inc (8.4%) and Johnson & Johnson (6.0%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| Fidelity MSCI Health Care Index ETF | C000131667 | ARCX | FHLC |
Holdings
From latest NPORT-P, filed September 25th, 2024 for period ending July 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 10X Genomics Inc | Long | Equity-common | US | $949K | 46K | 0.03 |
| 4D Molecular Therapeutics Inc | Long | Equity-common | US | $249K | 14K | 0.01 |
| 89bio Inc | Long | Equity-common | US | $308K | 34K | 0.01 |
| Abbott Laboratories | Long | Equity-common | US | $89M | 838K | 2.91 |
| AbbVie Inc | Long | Equity-common | US | $158M | 855K | 5.19 |
| Acadia Healthcare Co Inc | Long | Equity-common | US | $3M | 44K | 0.09 |
| ACADIA Pharmaceuticals Inc | Long | Equity-common | US | $976K | 51K | 0.03 |
| Accolade Inc | Long | Equity-common | US | $140K | 34K | 0.00 |
| AdaptHealth Corp | Long | Equity-common | US | $401K | 35K | 0.01 |
| Addus HomeCare Corp | Long | Equity-common | US | $965K | 8K | 0.03 |
| ADMA Biologics Inc | Long | Equity-common | US | $1M | 105K | 0.04 |
| Agilent Technologies Inc | Long | Equity-common | US | $20M | 142K | 0.66 |
| agilon health Inc | Long | Equity-common | US | $1M | 147K | 0.03 |
| Agios Pharmaceuticals Inc | Long | Equity-common | US | $1M | 24K | 0.04 |
| Akero Therapeutics Inc | Long | Equity-common | US | $684K | 26K | 0.02 |
| Alector Inc | Long | Equity-common | US | $205K | 34K | 0.01 |
| Align Technology Inc | Long | Equity-common | US | $8M | 35K | 0.26 |
| Alignment Healthcare Inc | Long | Equity-common | US | $390K | 45K | 0.01 |
| Alkermes PLC | Long | Equity-common | IE | $2M | 78K | 0.07 |
| Allogene Therapeutics Inc | Long | Equity-common | US | $207K | 71K | 0.01 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $14M | 61K | 0.47 |
| Alphatec Holdings Inc | Long | Equity-common | US | $458K | 45K | 0.02 |
| Altimmune Inc | Long | Equity-common | US | $218K | 34K | 0.01 |
| ALX Oncology Holdings Inc | Long | Equity-common | US | $52K | 11K | 0.00 |
| Amedisys Inc | Long | Equity-common | US | $2M | 16K | 0.05 |
| Amgen Inc | Long | Equity-common | US | $86M | 259K | 2.82 |
| Amicus Therapeutics Inc | Long | Equity-common | US | $1M | 107K | 0.04 |
| AMN Healthcare Services Inc | Long | Equity-common | US | $1M | 18K | 0.04 |
| Amneal Pharmaceuticals Inc | Long | Equity-common | US | $434K | 59K | 0.01 |
| Amphastar Pharmaceuticals Inc | Long | Equity-common | US | $814K | 19K | 0.03 |
| AnaptysBio Inc | Long | Equity-common | US | $179K | 5K | 0.01 |
| ANI Pharmaceuticals Inc | Long | Equity-common | US | $549K | 8K | 0.02 |
| Apellis Pharmaceuticals Inc | Long | Equity-common | US | $2M | 38K | 0.05 |
| Apogee Therapeutics Inc | Long | Equity-common | US | $491K | 10K | 0.02 |
| Arcellx Inc | Long | Equity-common | US | $954K | 15K | 0.03 |
| Arcturus Therapeutics Holdings Inc | Long | Equity-common | US | $270K | 12K | 0.01 |
| Arcus Biosciences Inc | Long | Equity-common | US | $407K | 25K | 0.01 |
| Arcutis Biotherapeutics Inc | Long | Equity-common | US | $503K | 50K | 0.02 |
| Ardelyx Inc | Long | Equity-common | US | $622K | 112K | 0.02 |
| Arrowhead Pharmaceuticals Inc | Long | Equity-common | US | $2M | 60K | 0.06 |
| ARS Pharmaceuticals Inc | Long | Equity-common | US | $193K | 18K | 0.01 |
| Artivion Inc | Long | Equity-common | US | $497K | 18K | 0.02 |
| Arvinas Inc | Long | Equity-common | US | $635K | 23K | 0.02 |
| Astrana Health Inc | Long | Equity-common | US | $1M | 21K | 0.04 |
| AtriCure Inc | Long | Equity-common | US | $494K | 23K | 0.02 |
| Atrion Corp | Long | Equity-common | US | $322K | 703 | 0.01 |
| Aurinia Pharmaceuticals Inc | Long | Equity-common | CA | $379K | 64K | 0.01 |
| Avanos Medical Inc | Long | Equity-common | US | $533K | 22K | 0.02 |
| Avantor Inc | Long | Equity-common | US | $9M | 328K | 0.29 |
| Avid Bioservices Inc | Long | Equity-common | US | $310K | 30K | 0.01 |
| Avidity Biosciences Inc | Long | Equity-common | US | $2M | 38K | 0.06 |
| Axonics Inc | Long | Equity-common | US | $2M | 24K | 0.05 |
| Axsome Therapeutics Inc | Long | Equity-common | US | $1M | 15K | 0.04 |
| Azenta Inc | Long | Equity-common | US | $2M | 24K | 0.05 |
| Baxter International Inc | Long | Equity-common | US | $9M | 245K | 0.29 |
| Beam Therapeutics Inc | Long | Equity-common | US | $1M | 33K | 0.03 |
| Becton Dickinson & Co | Long | Equity-common | US | $34M | 140K | 1.10 |
| Bio-Rad Laboratories Inc | Long | Equity-common | US | $3M | 10K | 0.11 |
| Bio-Techne Corp | Long | Equity-common | US | $6M | 76K | 0.20 |
| BioCryst Pharmaceuticals Inc | Long | Equity-common | US | $654K | 90K | 0.02 |
| Biogen Inc | Long | Equity-common | US | $15M | 70K | 0.49 |
| Biohaven Ltd | Long | Equity-common | VG | $1M | 36K | 0.05 |
| BioLife Solutions Inc | Long | Equity-common | US | $438K | 18K | 0.01 |
| BioMarin Pharmaceutical Inc | Long | Equity-common | US | $8M | 92K | 0.25 |
| Biomea Fusion Inc | Long | Equity-common | US | $75K | 13K | 0.00 |
| Blueprint Medicines Corp | Long | Equity-common | US | $3M | 28K | 0.10 |
| Boston Scientific Corp | Long | Equity-common | US | $52M | 710K | 1.72 |
| Bridgebio Pharma Inc | Long | Equity-common | US | $1M | 53K | 0.05 |
| BrightSpring Health Services Inc | Long | Equity-common | US | $307K | 25K | 0.01 |
| Bristol-Myers Squibb Co | Long | Equity-common | US | $47M | 979K | 1.52 |
| Brookdale Senior Living Inc | Long | Equity-common | US | $663K | 86K | 0.02 |
| Bruker Corp | Long | Equity-common | US | $3M | 46K | 0.10 |
| Cabaletta Bio Inc | Long | Equity-common | US | $123K | 17K | 0.00 |
| Cardinal Health Inc | Long | Equity-common | US | $12M | 117K | 0.39 |
| Cargo Therapeutics Inc | Long | Equity-common | US | $119K | 7K | 0.00 |
| Cassava Sciences Inc | Long | Equity-common | US | $447K | 20K | 0.01 |
| Castle Biosciences Inc | Long | Equity-common | US | $316K | 13K | 0.01 |
| Catalent Inc | Long | Equity-common | US | $5M | 87K | 0.17 |
| Catalyst Pharmaceuticals Inc | Long | Equity-common | US | $882K | 51K | 0.03 |
| Celldex Therapeutics Inc | Long | Equity-common | US | $1M | 28K | 0.03 |
| Cencora Inc | Long | Equity-common | US | $21M | 87K | 0.68 |
| Centene Corp | Long | Equity-common | US | $20M | 258K | 0.65 |
| Cerevel Therapeutics Holdings Inc | Long | Equity-common | US | $2M | 35K | 0.05 |
| Certara Inc | Long | Equity-common | US | $838K | 54K | 0.03 |
| CG oncology Inc | Long | Equity-common | US | $322K | 10K | 0.01 |
| Charles River Laboratories International Inc | Long | Equity-common | US | $6M | 25K | 0.20 |
| Chemed Corp | Long | Equity-common | US | $4M | 7K | 0.13 |
| Cigna Group/The | Long | Equity-common | US | $48M | 137K | 1.56 |
| Cogent Biosciences Inc | Long | Equity-common | US | $284K | 30K | 0.01 |
| Collegium Pharmaceutical Inc | Long | Equity-common | US | $602K | 16K | 0.02 |
| Community Health Systems Inc | Long | Equity-common | US | $348K | 66K | 0.01 |
| CONMED Corp | Long | Equity-common | US | $1M | 15K | 0.03 |
| CONTRA AKOUOS INC | Derivative-equity | US | $2K | 12K | 0.00 | |
| CONTRA CHINOOK THERAPE | Derivative-equity | US | $0.24 | 24K | 0.00 | |
| CONTRA SCILEX HLDG CO | Long | Equity-common | US | $44K | 35K | 0.00 |
| Cooper Cos Inc/The | Long | Equity-common | US | $9M | 96K | 0.29 |
| Corcept Therapeutics Inc | Long | Equity-common | US | $2M | 45K | 0.06 |
| CorVel Corp | Long | Equity-common | US | $1M | 5K | 0.05 |
| Crinetics Pharmaceuticals Inc | Long | Equity-common | US | $2M | 32K | 0.06 |
| CRISPR Therapeutics AG | Long | Equity-common | CH | $2M | 39K | 0.07 |
| Cross Country Healthcare Inc | Long | Equity-common | US | $308K | 17K | 0.01 |
| CryoPort Inc | Long | Equity-common | US | $217K | 23K | 0.01 |
| Cullinan Therapeutics Inc | Long | Equity-common | US | $357K | 18K | 0.01 |
| CVS Health Corp | Long | Equity-common | US | $37M | 608K | 1.20 |
| Cytek Biosciences Inc | Long | Equity-common | US | $344K | 51K | 0.01 |
| Cytokinetics Inc | Long | Equity-common | US | $3M | 48K | 0.09 |
| Danaher Corp | Long | Equity-common | US | $94M | 340K | 3.08 |
| DaVita Inc | Long | Equity-common | US | $4M | 26K | 0.12 |
| Day One Biopharmaceuticals Inc | Long | Equity-common | US | $328K | 23K | 0.01 |
| Definitive Healthcare Corp | Long | Equity-common | US | $95K | 24K | 0.00 |
| Denali Therapeutics Inc | Long | Equity-common | US | $1M | 57K | 0.05 |
| DENTSPLY SIRONA Inc | Long | Equity-common | US | $3M | 100K | 0.09 |
| Dexcom Inc | Long | Equity-common | US | $13M | 186K | 0.41 |
| Dianthus Therapeutics Inc | Long | Equity-common | US | $127K | 4K | 0.00 |
| Disc Medicine Inc | Long | Equity-common | US | $344K | 8K | 0.01 |
| Doximity Inc | Long | Equity-common | US | $1M | 53K | 0.05 |
| Dynavax Technologies Corp | Long | Equity-common | US | $664K | 59K | 0.02 |
| Dyne Therapeutics Inc | Long | Equity-common | US | $1M | 26K | 0.04 |
| E-MINI RUSS 2000 SEP24 (Chicago Mercantile Exchange) | Derivative-equity | US | $72K | – | 0.00 | |
| Edgewise Therapeutics Inc | Long | Equity-common | US | $307K | 18K | 0.01 |
| Editas Medicine Inc | Long | Equity-common | US | $217K | 40K | 0.01 |
| Edwards Lifesciences Corp | Long | Equity-common | US | $18M | 290K | 0.60 |
| Elanco Animal Health Inc | Long | Equity-common | US | $3M | 239K | 0.10 |
| Elevance Health Inc | Long | Equity-common | US | $60M | 112K | 1.96 |
| Eli Lilly & Co | Long | Equity-common | US | $314M | 390K | 10.28 |
| Embecta Corp | Long | Equity-common | US | $426K | 27K | 0.01 |
| Encompass Health Corp | Long | Equity-common | US | $4M | 48K | 0.15 |
| Enhabit Inc | Long | Equity-common | US | $209K | 20K | 0.01 |
| Enliven Therapeutics Inc | Long | Equity-common | US | $239K | 9K | 0.01 |
| Enovis Corp | Long | Equity-common | US | $1M | 26K | 0.04 |
| Ensign Group Inc/The | Long | Equity-common | US | $4M | 27K | 0.13 |
| Entrada Therapeutics Inc | Long | Equity-common | US | $116K | 7K | 0.00 |
| Envista Holdings Corp | Long | Equity-common | US | $1M | 83K | 0.05 |
| Establishment Labs Holdings Inc | Long | Equity-common | VG | $407K | 9K | 0.01 |
| Evolent Health Inc | Long | Equity-common | US | $1M | 50K | 0.04 |
| Evolus Inc | Long | Equity-common | US | $313K | 25K | 0.01 |
| Exact Sciences Corp | Long | Equity-common | US | $4M | 87K | 0.13 |
| Exelixis Inc | Long | Equity-common | US | $3M | 128K | 0.10 |
| EyePoint Pharmaceuticals Inc | Long | Equity-common | US | $235K | 24K | 0.01 |
| Fate Therapeutics Inc | Long | Equity-common | US | $234K | 44K | 0.01 |
| Fortrea Holdings Inc | Long | Equity-common | US | $1M | 42K | 0.04 |
| Fulgent Genetics Inc | Long | Equity-common | US | $247K | 10K | 0.01 |
| GE HealthCare Technologies Inc | Long | Equity-common | US | $18M | 209K | 0.58 |
| Geron Corp | Long | Equity-common | US | $930K | 196K | 0.03 |
| Gilead Sciences Inc | Long | Equity-common | US | $46M | 602K | 1.50 |
| Glaukos Corp | Long | Equity-common | US | $3M | 24K | 0.09 |
| Globus Medical Inc | Long | Equity-common | US | $4M | 55K | 0.13 |
| GoodRx Holdings Inc | Long | Equity-common | US | $348K | 38K | 0.01 |
| GRAIL Inc | Long | Equity-common | US | $197K | 13K | 0.01 |
| Guardant Health Inc | Long | Equity-common | US | $2M | 59K | 0.07 |
| Haemonetics Corp | Long | Equity-common | US | $2M | 24K | 0.07 |
| Halozyme Therapeutics Inc | Long | Equity-common | US | $3M | 61K | 0.11 |
| Harmony Biosciences Holdings Inc | Long | Equity-common | US | $502K | 15K | 0.02 |
| HCA Healthcare Inc | Long | Equity-common | US | $35M | 96K | 1.14 |
| HealthEquity Inc | Long | Equity-common | US | $3M | 42K | 0.11 |
| HealthStream Inc | Long | Equity-common | US | $350K | 12K | 0.01 |
| Henry Schein Inc | Long | Equity-common | US | $4M | 62K | 0.15 |
| HilleVax Inc | Long | Equity-common | US | $17K | 9K | 0.00 |
| Hims & Hers Health Inc | Long | Equity-common | US | $1M | 70K | 0.05 |
| Hologic Inc | Long | Equity-common | US | $9M | 113K | 0.30 |
| Humana Inc | Long | Equity-common | US | $21M | 58K | 0.69 |
| ICU Medical Inc | Long | Equity-common | US | $1M | 10K | 0.04 |
| Ideaya Biosciences Inc | Long | Equity-common | US | $1M | 31K | 0.04 |
| IDEXX Laboratories Inc | Long | Equity-common | US | $19M | 40K | 0.63 |
| Illumina Inc | Long | Equity-common | US | $9M | 77K | 0.31 |
| ImmunityBio Inc | Long | Equity-common | US | $339K | 66K | 0.01 |
| Immunome Inc | Long | Equity-common | US | $300K | 19K | 0.01 |
| Immunovant Inc | Long | Equity-common | US | $705K | 24K | 0.02 |
| Inari Medical Inc | Long | Equity-common | US | $1M | 25K | 0.04 |
| Incyte Corp | Long | Equity-common | US | $5M | 76K | 0.16 |
| Innoviva Inc | Long | Equity-common | US | $508K | 27K | 0.02 |
| Insmed Inc | Long | Equity-common | US | $5M | 68K | 0.16 |
| Inspire Medical Systems Inc | Long | Equity-common | US | $2M | 15K | 0.07 |
| Insulet Corp | Long | Equity-common | US | $7M | 34K | 0.22 |
| Integer Holdings Corp | Long | Equity-common | US | $2M | 16K | 0.06 |
| Integra LifeSciences Holdings Corp | Long | Equity-common | US | $797K | 32K | 0.03 |
| Intellia Therapeutics Inc | Long | Equity-common | US | $1M | 44K | 0.04 |
| Intra-Cellular Therapies Inc | Long | Equity-common | US | $3M | 42K | 0.11 |
| Intuitive Surgical Inc | Long | Equity-common | US | $76M | 171K | 2.49 |
| Ionis Pharmaceuticals Inc | Long | Equity-common | US | $3M | 63K | 0.10 |
| Iovance Biotherapeutics Inc | Long | Equity-common | US | $840K | 96K | 0.03 |
| IQVIA Holdings Inc | Long | Equity-common | US | $22M | 88K | 0.71 |
| iRadimed Corp | Long | Equity-common | US | $166K | 4K | 0.01 |
| iRhythm Technologies Inc | Long | Equity-common | US | $1M | 15K | 0.04 |
| Ironwood Pharmaceuticals Inc | Long | Equity-common | US | $469K | 69K | 0.02 |
| iTeos Therapeutics Inc | Long | Equity-common | US | $192K | 11K | 0.01 |
| Janux Therapeutics Inc | Long | Equity-common | US | $405K | 10K | 0.01 |
| Jazz Pharmaceuticals PLC | Long | Equity-common | IE | $3M | 29K | 0.10 |
| Johnson & Johnson | Long | Equity-common | US | $184M | 1M | 6.01 |
| Keros Therapeutics Inc | Long | Equity-common | US | $699K | 14K | 0.02 |
| Kiniksa Pharmaceuticals International Plc | Long | Equity-common | GB | $513K | 19K | 0.02 |
| Krystal Biotech Inc | Long | Equity-common | US | $2M | 9K | 0.06 |
| Kura Oncology Inc | Long | Equity-common | US | $511K | 25K | 0.02 |
| Kymera Therapeutics Inc | Long | Equity-common | US | $1M | 22K | 0.03 |
| Kyverna Therapeutics Inc | Long | Equity-common | US | $63K | 7K | 0.00 |
| Labcorp Holdings Inc | Long | Equity-common | US | $9M | 41K | 0.29 |
| Lantheus Holdings Inc | Long | Equity-common | US | $3M | 33K | 0.11 |
| LeMaitre Vascular Inc | Long | Equity-common | US | $860K | 10K | 0.03 |
| LifeStance Health Group Inc | Long | Equity-common | US | $304K | 55K | 0.01 |
| Ligand Pharmaceuticals Inc | Long | Equity-common | US | $897K | 8K | 0.03 |
| Liquidia Corp | Long | Equity-common | US | $290K | 24K | 0.01 |
| LivaNova PLC | Long | Equity-common | GB | $1M | 26K | 0.04 |
| Longboard Pharmaceuticals Inc | Long | Equity-common | US | $458K | 14K | 0.01 |
| Lyell Immunopharma Inc | Long | Equity-common | US | $95K | 59K | 0.00 |
| MacroGenics Inc | Long | Equity-common | US | $85K | 22K | 0.00 |
| Madrigal Pharmaceuticals Inc | Long | Equity-common | US | $2M | 6K | 0.06 |
| MannKind Corp | Long | Equity-common | US | $757K | 131K | 0.02 |
| Maravai LifeSciences Holdings Inc | Long | Equity-common | US | $532K | 55K | 0.02 |
| Masimo Corp | Long | Equity-common | US | $2M | 22K | 0.08 |
| MaxCyte Inc | Long | Equity-common | US | $229K | 48K | 0.01 |
| McKesson Corp | Long | Equity-common | US | $39M | 63K | 1.28 |
| Medpace Holdings Inc | Long | Equity-common | US | $5M | 13K | 0.16 |
| Medtronic PLC | Long | Equity-common | IE | $52M | 641K | 1.69 |
| Merck & Co Inc | Long | Equity-common | US | $138M | 1M | 4.53 |
| Merit Medical Systems Inc | Long | Equity-common | US | $2M | 28K | 0.08 |
| Merus NV | Long | Equity-common | NL | $1M | 19K | 0.03 |
| Mesa Laboratories Inc | Long | Equity-common | US | $285K | 2K | 0.01 |
| Mettler-Toledo International Inc | Long | Equity-common | US | $16M | 10K | 0.51 |
| MiMedx Group Inc | Long | Equity-common | US | $439K | 59K | 0.01 |
| Mind Medicine MindMed Inc | Long | Equity-common | CA | $252K | 27K | 0.01 |
| Mirum Pharmaceuticals Inc | Long | Equity-common | US | $644K | 16K | 0.02 |
| Moderna Inc | Long | Equity-common | US | $19M | 157K | 0.61 |
| Molina Healthcare Inc | Long | Equity-common | US | $10M | 28K | 0.32 |
| MoonLake Immunotherapeutics | Long | Equity-common | KY | $316K | 8K | 0.01 |
| Morphic Holding Inc | Long | Equity-common | US | $828K | 15K | 0.03 |
| Multiplan Corp | Long | Equity-common | US | $57K | 126K | 0.00 |
| Myriad Genetics Inc | Long | Equity-common | US | $1M | 43K | 0.04 |
| Natera Inc | Long | Equity-common | US | $6M | 55K | 0.19 |
| National HealthCare Corp | Long | Equity-common | US | $921K | 7K | 0.03 |
| National Research Corp | Long | Equity-common | US | $187K | 7K | 0.01 |
| Neogen Corp | Long | Equity-common | US | $2M | 99K | 0.06 |
| NeoGenomics Inc | Long | Equity-common | US | $1M | 62K | 0.04 |
| Neurocrine Biosciences Inc | Long | Equity-common | US | $7M | 48K | 0.22 |
| Nevro Corp | Long | Equity-common | US | $134K | 13K | 0.00 |
| Newamsterdam Pharma Co NV | Long | Equity-common | NL | $148K | 9K | 0.00 |
| Novavax Inc | Long | Equity-common | US | $779K | 61K | 0.03 |
| Novocure Ltd | Long | Equity-common | JE | $1M | 50K | 0.04 |
| Nurix Therapeutics Inc | Long | Equity-common | US | $533K | 24K | 0.02 |
| Nuvalent Inc | Long | Equity-common | US | $1M | 14K | 0.04 |
| Nuvation Bio Inc | Long | Equity-common | US | $250K | 65K | 0.01 |
| Ocular Therapeutix Inc | Long | Equity-common | US | $411K | 49K | 0.01 |
| Olema Pharmaceuticals Inc | Long | Equity-common | US | $249K | 15K | 0.01 |
| OmniAb Inc | Long | Equity-common | US | $208K | 43K | 0.01 |
| OMNIAB INC | Long | Equity-common | US | $10K | 3K | 0.00 |
| OMNIAB INC | Long | Equity-common | US | $9K | 3K | 0.00 |
| Omnicell Inc | Long | Equity-common | US | $639K | 22K | 0.02 |
| OPKO Health Inc | Long | Equity-common | US | $239K | 168K | 0.01 |
| Option Care Health Inc | Long | Equity-common | US | $2M | 84K | 0.08 |
| OraSure Technologies Inc | Long | Equity-common | US | $166K | 37K | 0.01 |
| Organon & Co | Long | Equity-common | US | $3M | 124K | 0.09 |
| ORIC Pharmaceuticals Inc | Long | Equity-common | US | $182K | 16K | 0.01 |
| Orthofix Medical Inc | Long | Equity-common | US | $290K | 18K | 0.01 |
| OrthoPediatrics Corp | Long | Equity-common | US | $252K | 8K | 0.01 |
| Owens & Minor Inc | Long | Equity-common | US | $577K | 35K | 0.02 |
| Pacific Biosciences of California Inc | Long | Equity-common | US | $237K | 115K | 0.01 |
| Pacira BioSciences Inc | Long | Equity-common | US | $456K | 22K | 0.01 |
| Paragon 28 Inc | Long | Equity-common | US | $171K | 22K | 0.01 |
| Patterson Cos Inc | Long | Equity-common | US | $983K | 39K | 0.03 |
| Pediatrix Medical Group Inc | Long | Equity-common | US | $326K | 39K | 0.01 |
| Pennant Group Inc/The | Long | Equity-common | US | $424K | 14K | 0.01 |
| Penumbra Inc | Long | Equity-common | US | $3M | 18K | 0.10 |
| Perrigo Co PLC | Long | Equity-common | IE | $2M | 66K | 0.06 |
| Perspective Therapeutics Inc | Long | Equity-common | US | $231K | 17K | 0.01 |
| PetIQ Inc | Long | Equity-common | US | $292K | 13K | 0.01 |
| Pfizer Inc | Long | Equity-common | US | $83M | 3M | 2.73 |
| Phathom Pharmaceuticals Inc | Long | Equity-common | US | $153K | 13K | 0.01 |
| Phibro Animal Health Corp | Long | Equity-common | US | $186K | 10K | 0.01 |
| Phreesia Inc | Long | Equity-common | US | $636K | 25K | 0.02 |
| Pliant Therapeutics Inc | Long | Equity-common | US | $308K | 22K | 0.01 |
| Praxis Precision Medicines Inc | Long | Equity-common | US | $452K | 8K | 0.01 |
| Premier Inc | Long | Equity-common | US | $1M | 57K | 0.04 |
| Prestige Consumer Healthcare Inc | Long | Equity-common | US | $2M | 24K | 0.06 |
| Privia Health Group Inc | Long | Equity-common | US | $970K | 47K | 0.03 |
| PROCEPT BioRobotics Corp | Long | Equity-common | US | $1M | 22K | 0.05 |
| Progyny Inc | Long | Equity-common | US | $1M | 42K | 0.04 |
| Protagonist Therapeutics Inc | Long | Equity-common | US | $790K | 21K | 0.03 |
| Prothena Corp PLC | Long | Equity-common | IE | $392K | 17K | 0.01 |
| PTC Therapeutics Inc | Long | Equity-common | US | $1M | 33K | 0.04 |
| Quanterix Corp | Long | Equity-common | US | $256K | 17K | 0.01 |
| Quest Diagnostics Inc | Long | Equity-common | US | $8M | 53K | 0.25 |
| QuidelOrtho Corp | Long | Equity-common | US | $1M | 26K | 0.03 |
| R1 RCM Inc | Long | Equity-common | US | $1M | 81K | 0.03 |
| Radius Health, Inc. (CONTRA RADIUS HEALTH I) | Derivative-equity | US | $0.2 | 20K | 0.00 | |
| RadNet Inc | Long | Equity-common | US | $2M | 30K | 0.06 |
| Recursion Pharmaceuticals Inc | Long | Equity-common | US | $674K | 82K | 0.02 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $56M | 52K | 1.84 |
| REGENXBIO Inc | Long | Equity-common | US | $284K | 20K | 0.01 |
| Relay Therapeutics Inc | Long | Equity-common | US | $357K | 43K | 0.01 |
| Repligen Corp | Long | Equity-common | US | $4M | 26K | 0.14 |
| Replimune Group Inc | Long | Equity-common | US | $221K | 22K | 0.01 |
| ResMed Inc | Long | Equity-common | US | $15M | 71K | 0.50 |
| Revance Therapeutics Inc | Long | Equity-common | US | $185K | 49K | 0.01 |
| REVOLUTION Medicines Inc | Long | Equity-common | US | $3M | 56K | 0.08 |
| Revvity Inc | Long | Equity-common | US | $7M | 60K | 0.25 |
| Rhythm Pharmaceuticals Inc | Long | Equity-common | US | $1M | 22K | 0.03 |
| Rocket Pharmaceuticals Inc | Long | Equity-common | US | $738K | 31K | 0.02 |
| Roivant Sciences Ltd | Long | Equity-common | BM | $2M | 175K | 0.06 |
| Royalty Pharma PLC | Long | Equity-common | GB | $5M | 183K | 0.17 |
| RxSight Inc | Long | Equity-common | US | $616K | 13K | 0.02 |
| Sage Therapeutics Inc | Long | Equity-common | US | $238K | 22K | 0.01 |
| Sana Biotechnology Inc | Long | Equity-common | US | $389K | 64K | 0.01 |
| Sarepta Therapeutics Inc | Long | Equity-common | US | $6M | 41K | 0.19 |
| Savara Inc | Long | Equity-common | US | $219K | 48K | 0.01 |
| Scholar Rock Holding Corp | Long | Equity-common | US | $174K | 19K | 0.01 |
| Schrodinger Inc/United States | Long | Equity-common | US | $678K | 30K | 0.02 |
| Select Medical Holdings Corp | Long | Equity-common | US | $2M | 53K | 0.07 |
| SI-BONE Inc | Long | Equity-common | US | $279K | 18K | 0.01 |
| SIGA Technologies Inc | Long | Equity-common | US | $217K | 22K | 0.01 |
| Silk Road Medical Inc | Long | Equity-common | US | $485K | 18K | 0.02 |
| Simulations Plus Inc | Long | Equity-common | US | $330K | 8K | 0.01 |
| Soleno Therapeutics Inc | Long | Equity-common | US | $354K | 7K | 0.01 |
| Solventum Corp | Long | Equity-common | US | $4M | 71K | 0.14 |
| Sotera Health Co | Long | Equity-common | US | $947K | 68K | 0.03 |
| SpringWorks Therapeutics Inc | Long | Equity-common | US | $959K | 27K | 0.03 |
| Spyre Therapeutics Inc | Long | Equity-common | US | $232K | 8K | 0.01 |
| STAAR Surgical Co | Long | Equity-common | US | $766K | 19K | 0.03 |
| Standard BioTools Inc | Long | Equity-common | US | $269K | 120K | 0.01 |
| State Street Institutional Treasury Plus Money Market Fund (State Street Global Advisors) | Long | Short-term investment vehicle | US | $8M | 8M | 0.26 |
| STERIS PLC | Long | Equity-common | IE | $11M | 48K | 0.37 |
| Stoke Therapeutics Inc | Long | Equity-common | US | $244K | 16K | 0.01 |
| Stryker Corp | Long | Equity-common | US | $54M | 165K | 1.77 |
| Supernus Pharmaceuticals Inc | Long | Equity-common | US | $799K | 27K | 0.03 |
| Surgery Partners Inc | Long | Equity-common | US | $1M | 34K | 0.03 |
| Syndax Pharmaceuticals Inc | Long | Equity-common | US | $837K | 37K | 0.03 |
| Tandem Diabetes Care Inc | Long | Equity-common | US | $1M | 31K | 0.04 |
| Tango Therapeutics Inc | Long | Equity-common | US | $187K | 19K | 0.01 |
| Tarsus Pharmaceuticals Inc | Long | Equity-common | US | $282K | 12K | 0.01 |
| Teladoc Health Inc | Long | Equity-common | US | $777K | 82K | 0.03 |
| Teleflex Inc | Long | Equity-common | US | $5M | 23K | 0.16 |
| Tenet Healthcare Corp | Long | Equity-common | US | $6M | 43K | 0.21 |
| TG Therapeutics Inc | Long | Equity-common | US | $1M | 71K | 0.05 |
| Theravance Biopharma Inc | Long | Equity-common | KY | $171K | 17K | 0.01 |
| Thermo Fisher Scientific Inc | Long | Equity-common | US | $113M | 184K | 3.70 |
| Tilray Brands Inc | Long | Equity-common | US | $777K | 383K | 0.03 |
| Tourmaline Bio Inc | Long | Equity-common | US | $100K | 6K | 0.00 |
| TransMedics Group Inc | Long | Equity-common | US | $2M | 16K | 0.07 |
| Travere Therapeutics Inc | Long | Equity-common | US | $304K | 32K | 0.01 |
| Treace Medical Concepts Inc | Long | Equity-common | US | $158K | 22K | 0.01 |
| Twist Bioscience Corp | Long | Equity-common | US | $2M | 28K | 0.05 |
| UFP Technologies Inc | Long | Equity-common | US | $1M | 4K | 0.04 |
| Ultragenyx Pharmaceutical Inc | Long | Equity-common | US | $2M | 36K | 0.05 |
| United Therapeutics Corp | Long | Equity-common | US | $7M | 22K | 0.22 |
| UnitedHealth Group Inc | Long | Equity-common | US | $257M | 445K | 8.40 |
| Universal Health Services Inc | Long | Equity-common | US | $6M | 29K | 0.20 |
| US Physical Therapy Inc | Long | Equity-common | US | $709K | 7K | 0.02 |
| Varex Imaging Corp | Long | Equity-common | US | $287K | 19K | 0.01 |
| Vaxcyte Inc | Long | Equity-common | US | $4M | 44K | 0.11 |
| Veeva Systems Inc | Long | Equity-common | US | $14M | 74K | 0.46 |
| Vera Therapeutics Inc | Long | Equity-common | US | $625K | 17K | 0.02 |
| Veracyte Inc | Long | Equity-common | US | $879K | 37K | 0.03 |
| Vericel Corp | Long | Equity-common | US | $1M | 22K | 0.04 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $62M | 125K | 2.02 |
| Verve Therapeutics Inc | Long | Equity-common | US | $209K | 30K | 0.01 |
| Viatris Inc | Long | Equity-common | US | $7M | 573K | 0.23 |
| Viking Therapeutics Inc | Long | Equity-common | US | $3M | 48K | 0.09 |
| Vir Biotechnology Inc | Long | Equity-common | US | $458K | 45K | 0.01 |
| Viridian Therapeutics Inc | Long | Equity-common | US | $383K | 23K | 0.01 |
| Waters Corp | Long | Equity-common | US | $10M | 29K | 0.32 |
| WaVe Life Sciences Ltd | Long | Equity-common | SG | $264K | 40K | 0.01 |
| West Pharmaceutical Services Inc | Long | Equity-common | US | $11M | 35K | 0.35 |
| XAV HEALTH CARE SEP24 (Chicago Mercantile Exchange) | Derivative-equity | US | $186K | – | 0.01 | |
| Xencor Inc | Long | Equity-common | US | $546K | 27K | 0.02 |
| Xenon Pharmaceuticals Inc | Long | Equity-common | CA | $1M | 31K | 0.04 |
| Y-mAbs Therapeutics Inc | Long | Equity-common | US | $182K | 15K | 0.01 |
| Zentalis Pharmaceuticals Inc | Long | Equity-common | US | $101K | 26K | 0.00 |
| Zimmer Biomet Holdings Inc | Long | Equity-common | US | $11M | 99K | 0.36 |
| Zoetis Inc | Long | Equity-common | US | $40M | 221K | 1.30 |
| Zymeworks Inc | Long | Equity-common | US | $218K | 21K | 0.01 |
Address
FIDELITY COVINGTON TRUST
245 SUMMER STREET
BOSTON
Massachusetts
02210
United States of America
Directors
David M. Thomas
Thomas P. Bostick
Vicki L. Fuller
Patricia L. Kampling
Susan Tomasky
Bettina Doulton
Michael E. Wiley
Thomas A. Kennedy
Vijay C. Advani
Oscar Munoz
Karen Peetz
Robert A. Lawrence
Donald F. Donahue
Transfer Agents
State Street Bank and Trust Company
Pricing Services
London Stock Exchange Group PLC
Bloomberg L.P.
ICE Data Services, Inc.
Custodians
State Street Bank and Trust Company
Shareholder Servicing Agents
State Street Bank and Trust Company
Admins
Fidelity Service Company, Inc.
Brokers
Cowen and Company, LLC
Jefferies LLC
BNP Paribas Securities Corp.
Goldman Sachs & Co. LLC
Morgan Stanley & Co. LLC
BNY Capital Markets, LLC
UBS Securities LLC
Wells Fargo Securities, LLC
Nomura Securities International, Inc.
RBC Capital Markets, LLC